Anika Therapeutics ANIK EV / sales
EV / sales at other companies
Other financials
Where this comes from
Calculated from Anika Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Anika Therapeutics's ev / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Anika Therapeutics's EV / sales?
- Anika Therapeutics (ANIK) reported EV / sales of 1.5× in Q1 2026.
- How has Anika Therapeutics's EV / sales changed year-over-year?
- Anika Therapeutics's EV / sales decreased by 11.1% year-over-year, from 1.7× to 1.5×.
- What is the long-term trend for Anika Therapeutics's EV / sales?
- Over 5 years (2020 to 2025), Anika Therapeutics's EV / sales has grown at a -26.5% compound annual growth rate (CAGR), from 4.4× to 1×.
- What does EV / sales mean?
- Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.